Jessica Cupac

Jessica Cupac, PharmD, serves as an Adjunct Assistant Professor in the Department of Pharmacy Practice and Science at the University of Kentucky College of Pharmacy while concurrently working as a hematology/oncology clinical pharmacist at the University of Kentucky Markey Cancer Center. Her clinical specialization encompasses inpatient and outpatient malignant hematology and stem cell transplant services.

Her educational foundation includes a Bachelor of Science in Chemistry from the University of the Cumberlands and a Doctor of Pharmacy from the University of Kentucky College of Pharmacy. She completed both PGY1 pharmacy practice and PGY2 hematology/oncology specialty residencies at UK Healthcare.

Dr. Cupac's research program centers on hematology/oncology with critical focus areas in lymphomas, allogeneic stem cell transplantation, and cardiovascular toxicity of chemotherapy. Her work bridges clinical pharmacy practice with cancer therapeutics to optimize pharmacotherapy safety and efficacy for complex hematologic malignancies.

Publication analysis reveals consistent themes in drug safety optimization for hematologic cancers, including specialized dosing protocols for obese patients, management of immunotherapy-related neurological complications, and nephrotoxicity mitigation strategies with antibiotic combinations.

No scientific awards were documented in the available profile information.

As an educator, Dr. Cupac precepts pharmacy students and residents across inpatient malignant hematology, blood & marrow transplant services, and ambulatory hematology rotations while contributing to the oncology therapeutics curriculum. Her clinical and research activities operate within the Markey Cancer Center's integrated care framework without specific grant details provided.

Dr. Cupac functions as a core member of the interdisciplinary hematology/oncology team at Markey Cancer Center, collaborating with physicians, nurses, and specialists to deliver comprehensive care for patients undergoing stem cell transplantation and treatment for hematologic malignancies.